PMHS (Polomar Health Services) 3-Year RORE % : 63.64% (As of Mar. 2026)


PMHS Polomar Health Services Inc PMHS
34 GF Score
Price $0.12
GF Value $12.39
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Polomar Health Services 3-Year RORE %?

Polomar Health Services PMHS 34 3-Year RORE % is 63.64 as of Mar. 2026. GuruFocus rates PMHS with a GF Score™ of 34/100 and a GF Value™ of $12.39 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Polomar Health Services ranks better than 86.96% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Polomar Health Services's 3-Year RORE % for the quarter that ended in Mar. 2026 was 63.64%.

The industry rank for Polomar Health Services's 3-Year RORE % or its related term are showing as below:

PMHS's 3-Year RORE % is ranked better than
86.96% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs PMHS: 63.64

Polomar Health Services  (OTCPK:PMHS) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Polomar Health Services 3-Year RORE % Related Terms


Polomar Health Services 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Polomar Health Services's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polomar Health Services 3-Year RORE % Chart

Polomar Health Services Annual Data
Trend Dec07 Dec08 Dec09 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial 0.00 0.00 0.00 917.65 67.00

Polomar Health Services Quarterly Data
Dec09 Mar10 Jun10 Sep10 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 427.03 -163.27 -128.80 67.00 63.64

PMHS vs DHTI, RDGT, BLMH: 3-Year RORE % Comparison

For the Pharmaceutical Retailers subindustry, Polomar Health Services's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polomar Health Services 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Polomar Health Services's 3-Year RORE % falls into.


PMHS
34GF Score
Polomar Health Services Inc PMHS
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polomar Health Services 3-Year RORE % Calculation

Polomar Health Services's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.37--0.055 )/( -0.495-0 )
=-0.315/-0.495
=63.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 63.64 mean?
Polomar Health Services (PMHS) has a 3-Year RORE % of 63.64 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #79 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 13%.
Is Polomar Health Services' 3-Year RORE % too high?
Polomar Health Services' current 3-Year RORE % is 63.64. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. Polomar Health Services' value of 63.64 is 32535.9% above this industry median. Based on the distribution chart, Polomar Health Services ranks #79 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Polomar Health Services has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' 3-Year RORE % compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #79 out of 606 companies for 3-Year RORE %. This places Polomar Health Services in the top 13% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.20. Polomar Health Services' value of 63.64 is 32535.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polomar Health Services's current 3-Year RORE % of 63.64 is 32535.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current 3-Year RORE % is 63.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.39, compared to a current price of $0.12 — trading 99% below its estimated fair value. The current 3-Year RORE % is 63.64 and 32535.9% above the Healthcare Providers & Services industry median of 0.20. Polomar Health Services' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current 3-Year RORE % is 63.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polomar Health Services (PMHS) Overvalued in 2026?

Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued. The current stock price of $0.12 is trading 99% below its estimated GF Value™ of $12.39. GuruFocus considers Polomar Health Services to be Possible Value Trap.

Key valuation signals for PMHS:

  • 3-Year RORE %: 63.64
  • GF Value™: $12.39 vs. price of $0.12 (99% below fair value)
  • GF Score™: 34/100 with 4 warning signs
  • Industry Position: 32535.9% above the Healthcare Providers & Services median (#79 of 606)

No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Polomar Health Services Business Description

Address 32866 US Highway, 19 N, Los Angeles, FL, USA, 34684
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
34GF Score

Get the complete analysis for PMHS

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$12.39
GF Value